ClinicalTrials.govpublic full text
A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies
hematologic neoplasms, jnj54179060, ibrutinib, nivolumab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802269
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.